GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zimmer Biomet Holdings Inc (STU:ZIM) » Definitions » Debt-to-Revenue

Zimmer Biomet Holdings (STU:ZIM) Debt-to-Revenue : 0.76 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Zimmer Biomet Holdings Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Zimmer Biomet Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €825 Mil. Zimmer Biomet Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €4,597 Mil. Zimmer Biomet Holdings's annualized Revenue for the quarter that ended in Dec. 2023 was €7,116 Mil. Zimmer Biomet Holdings's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.76.


Zimmer Biomet Holdings Debt-to-Revenue Historical Data

The historical data trend for Zimmer Biomet Holdings's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zimmer Biomet Holdings Debt-to-Revenue Chart

Zimmer Biomet Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.03 1.33 1.04 0.85 0.80

Zimmer Biomet Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.80 0.81 0.79 0.81 0.76

Competitive Comparison of Zimmer Biomet Holdings's Debt-to-Revenue

For the Medical Devices subindustry, Zimmer Biomet Holdings's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zimmer Biomet Holdings's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Zimmer Biomet Holdings's Debt-to-Revenue falls into.



Zimmer Biomet Holdings Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Zimmer Biomet Holdings's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(825.3 + 4596.554) / 6780.481
=0.80

Zimmer Biomet Holdings's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(825.3 + 4596.554) / 7116.288
=0.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.


Zimmer Biomet Holdings Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Zimmer Biomet Holdings's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Zimmer Biomet Holdings (STU:ZIM) Business Description

Traded in Other Exchanges
Address
345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Zimmer Biomet Holdings (STU:ZIM) Headlines